K Alexander Iwen1, Thomas Scherer, Martin Heni, Friedhelm Sayk, Toni Wellnitz, Felix Machleidt, Hubert Preissl, Hans-Ulrich Häring, Andreas Fritsche, Hendrik Lehnert, Christoph Buettner, Manfred Hallschmid. 1. Department of Internal Medicine I (K.A.I., F.S., T.W., F.M., H.L.), Section of Experimental and Clinical Endocrinology, University of Lübeck, 23538 Lübeck, Germany; Departments of Medicine and Neuroscience and Diabetes, Obesity and Metabolism Institute (DOMI) (T.S., C.B.), Icahn School of Medicine at Mt Sinai, New York, New York 10029; Department of Internal Medicine III (T.S.), Division of Endocrinology and Metabolism, Medical University of Vienna, 1090 Vienna, Austria; Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry (M.He., H.-U.H., A.F.), Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen (IDM) (M.He., H.P., H.-U.H., A.F., M.Ha.), fMEG (Fetal Magnetoencephalography) Center (H.P.), and Department of Medical Psychology and Behavioral Neurobiology (M.Ha.), University of Tübingen, 72076 Tübingen, Germany; and German Center for Diabetes Research (DZD) (M.He., H.P., H.-U.H., A.F., M.Ha.), 72076 Tübingen, Germany.
Abstract
CONTEXT: Insulin infused into the central nervous system of rats suppresses lipolysis in white adipose tissue, indicating a role of brain insulin in regulating systemic lipid metabolism. OBJECTIVE: We investigated whether central nervous insulin delivery suppresses lipolysis in healthy humans. DESIGN: Placebo-controlled, balanced within-subject comparisons were performed in both a main and an independent corroborative experiment. SETTING/PARTICIPANTS/INTERVENTION: Two groups of healthy volunteers were examined at the German University Clinics of Lübeck and Tübingen, respectively, with molecular analyses taking place at Mt Sinai School of Medicine (New York, New York). The 14 healthy male subjects of the main study and the 22 women and 5 men of the corroborative study each received 160 IU of human insulin intranasally. MAIN OUTCOME MEASURES: In the main study, we measured systemic levels of free fatty acids (FFAs), triglycerides, and glycerol and the rate of appearance of deuterated glycerol as an estimate of lipolysis before and after intranasal insulin administration. We also analyzed the expression of key lipolytic enzymes in sc fat biopsies and measured blood glucose and glucoregulatory hormones. In the corroborative study, FFA concentrations were assessed before and after intranasal insulin administration. RESULTS: In the main experiment, intranasal insulin suppressed circulating FFA concentrations and lipolysis (rate of appearance of deuterated glycerol) in the absence of significant changes in circulating insulin levels. Lipolytic protein expression in sc adipose tissue was not affected. The corroborative study confirmed that intranasal insulin lowers systemic FFA concentrations. CONCLUSIONS: Our findings indicate that brain insulin controls systemic lipolysis in healthy humans by predominantly acting on non-sc adipose tissue.
CONTEXT: Insulin infused into the central nervous system of rats suppresses lipolysis in white adipose tissue, indicating a role of brain insulin in regulating systemic lipid metabolism. OBJECTIVE: We investigated whether central nervous insulin delivery suppresses lipolysis in healthy humans. DESIGN: Placebo-controlled, balanced within-subject comparisons were performed in both a main and an independent corroborative experiment. SETTING/PARTICIPANTS/INTERVENTION: Two groups of healthy volunteers were examined at the German University Clinics of Lübeck and Tübingen, respectively, with molecular analyses taking place at Mt Sinai School of Medicine (New York, New York). The 14 healthy male subjects of the main study and the 22 women and 5 men of the corroborative study each received 160 IU of humaninsulin intranasally. MAIN OUTCOME MEASURES: In the main study, we measured systemic levels of free fatty acids (FFAs), triglycerides, and glycerol and the rate of appearance of deuterated glycerol as an estimate of lipolysis before and after intranasal insulin administration. We also analyzed the expression of key lipolytic enzymes in sc fat biopsies and measured blood glucose and glucoregulatory hormones. In the corroborative study, FFA concentrations were assessed before and after intranasal insulin administration. RESULTS: In the main experiment, intranasal insulin suppressed circulating FFA concentrations and lipolysis (rate of appearance of deuterated glycerol) in the absence of significant changes in circulating insulin levels. Lipolytic protein expression in sc adipose tissue was not affected. The corroborative study confirmed that intranasal insulin lowers systemic FFA concentrations. CONCLUSIONS: Our findings indicate that brain insulin controls systemic lipolysis in healthy humans by predominantly acting on non-sc adipose tissue.
Authors: Thomas Scherer; James O'Hare; Kelly Diggs-Andrews; Martina Schweiger; Bob Cheng; Claudia Lindtner; Elizabeth Zielinski; Prashant Vempati; Kai Su; Shveta Dighe; Thomas Milsom; Michelle Puchowicz; Ludger Scheja; Rudolf Zechner; Simon J Fisher; Stephen F Previs; Christoph Buettner Journal: Cell Metab Date: 2011-02-02 Impact factor: 27.287
Authors: Otto Tschritter; Hubert Preissl; Anita M Hennige; Michael Stumvoll; Katarina Porubska; Rebekka Frost; Hannah Marx; Benjamin Klösel; Werner Lutzenberger; Niels Birbaumer; Hans-Ulrich Häring; Andreas Fritsche Journal: Proc Natl Acad Sci U S A Date: 2006-07-28 Impact factor: 11.205
Authors: M Heni; S Kullmann; C Ketterer; M Guthoff; K Linder; R Wagner; K T Stingl; R Veit; H Staiger; H-U Häring; H Preissl; A Fritsche Journal: Diabetologia Date: 2012-03-21 Impact factor: 10.122
Authors: K Alexander Iwen; Eike T Wenzel; Volker Ott; Nina Perwitz; Peter Wellhöner; Hendrik Lehnert; Christoph Dodt; Johannes Klein Journal: Metabolism Date: 2010-04-27 Impact factor: 8.694
Authors: Alexander F Krapalis; Jacqueline Reiter; Felix Machleidt; K Alexander Iwen; Christoph Dodt; Hendrik Lehnert; Friedhelm Sayk Journal: Am J Physiol Regul Integr Comp Physiol Date: 2012-04-04 Impact factor: 3.619
Authors: Linda Koch; F Thomas Wunderlich; Jost Seibler; A Christine Könner; Brigitte Hampel; Sigrid Irlenbusch; Georg Brabant; C Ronald Kahn; Frieder Schwenk; Jens C Brüning Journal: J Clin Invest Date: 2008-06 Impact factor: 14.808
Authors: Matthias Blüher; M Dodson Michael; Odile D Peroni; Kohjiro Ueki; Nathan Carter; Barbara B Kahn; C Ronald Kahn Journal: Dev Cell Date: 2002-07 Impact factor: 12.270
Authors: Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan Journal: Nat Rev Neurol Date: 2018-01-29 Impact factor: 42.937
Authors: Thomas Scherer; Claudia Lindtner; James O'Hare; Martina Hackl; Elizabeth Zielinski; Angelika Freudenthaler; Sabina Baumgartner-Parzer; Klaus Tödter; Joerg Heeren; Martin Krššák; Ludger Scheja; Clemens Fürnsinn; Christoph Buettner Journal: Diabetes Date: 2016-02-09 Impact factor: 9.461